Changes to prescribing safer supply drugs approved by Ontario medical regulator

The Ontario medical regulator recently approved significant changes to the way doctors prescribe safer supply drugs, aiming to curb the flow of opioids onto the streets. The College of Physicians and Surgeons of Ontario's board of directors voted to implement these changes, which will soon take effect. The modifications will require physicians to prescribe safer supply medications only when combined with opioid agonist therapy, which involves drugs like Suboxone and methadone for treating opioid addiction.

Dr. Patrick Safieh, the chair of the board, emphasized the focus on public safety, stating that the goal is to prevent diversion and ensure patients adhere to opioid agonist therapy. Safer supply drugs, primarily hydromorphone, are less potent than illegal opioids like fentanyl. From now on, patients will need to obtain these medications under supervision rather than taking them home.

The change comes after concerns were raised about prescriptions being diverted to the black market. The board also considered input from various sources, including governments, medical associations, and public health officials, all of which indicated that hydromorphone is being diverted from safer supply prescriptions. While the policy may not work for all patients, such as those in rural areas or employed individuals, the college pledged to monitor the changes and make necessary adjustments. Health Minister Sylvia Jones has expressed support for the proposed modifications.